---
schema-version: v1.2.9
id: ISO22442-1-2015
title:
- content: Medical devices utilizing animal tissues and their derivatives
  language:
  - en
  script:
  - Latn
  format: text/plain
  type: title-main
- content: 'Part 1: Application of risk management'
  language:
  - en
  script:
  - Latn
  format: text/plain
  type: title-part
- content: 'Medical devices utilizing animal tissues and their derivatives - Part
    1: Application of risk management'
  language:
  - en
  script:
  - Latn
  format: text/plain
  type: main
- content: Dispositifs médicaux utilisant des tissus animaux et leurs dérivés
  language:
  - fr
  script:
  - Latn
  format: text/plain
  type: title-main
- content: 'Partie 1: Application de la gestion des risques'
  language:
  - fr
  script:
  - Latn
  format: text/plain
  type: title-part
- content: 'Dispositifs médicaux utilisant des tissus animaux et leurs dérivés - Partie
    1: Application de la gestion des risques'
  language:
  - fr
  script:
  - Latn
  format: text/plain
  type: main
link:
- content: https://www.iso.org/standard/68553.html
  type: src
- content: https://www.iso.org/contents/data/standard/06/85/68553.detail.rss
  type: rss
type: standard
docid:
- id: ISO 22442-1:2015
  type: ISO
  primary: true
- id: ISO 22442-1:2015(E)
  type: iso-reference
- id: urn:iso:std:iso:22442:-1:stage-95.99
  type: URN
docnumber: '22442'
date:
- type: published
  value: 2015-11
contributor:
- organization:
    name:
    - content: International Organization for Standardization
    abbreviation:
      content: ISO
    url: www.iso.org
  role:
  - type: publisher
edition:
  content: '2'
revdate: 2015-11
language:
- en
- fr
script:
- Latn
abstract:
- content: |-
    ISO 22442-1:2015 applies to medical devices other than in vitro diagnostic medical devices manufactured utilizing materials of animal origin, which are non-viable or have been rendered non-viable. It specifies, in conjunction with ISO 14971, a procedure to identify the hazards and hazardous situations associated with such devices, to estimate and evaluate the resulting risks, to control these risks, and to monitor the effectiveness of that control. Furthermore, it outlines the decision process for the residual risk acceptability, taking into account the balance of residual risk, as defined in ISO 14971, and expected medical benefit as compared to available alternatives. This part of ISO 22442 is intended to provide requirements and guidance on risk management related to the hazards typical of medical devices manufactured utilizing animal tissues or derivatives such as
    a)   contamination by bacteria, moulds or yeasts;
    b)   contamination by viruses;
    c)   contamination by agents causing Transmissible Spongiform Encephalopathies (TSE);
    d)   material responsible for undesired pyrogenic, immunological or toxicological reactions.
    For parasites and other unclassified pathogenic entities, similar principles can apply.
    ISO 22442-1:2015 does not stipulate levels of acceptability which, because they are determined by a multiplicity of factors, cannot be set down in such an International Standard except for some particular derivatives mentioned in Annex C. Annex C stipulates levels of TSE risk acceptability for tallow derivatives, animal charcoal, milk and milk derivatives, wool derivatives and amino acids.
    ISO 22442-1:2015 does not specify a quality management system for the control of all stages of production of medical devices.
    ISO 22442-1:2015 does not cover the utilization of human tissues in medical devices.
    NOTE 1       It is not a requirement of this part of ISO 22442 to have a full quality management system during manufacture. However, attention is drawn to International Standards for quality management systems (see ISO 13485) that control all stages of production or reprocessing of medical devices.
    NOTE 2       For guidance on the application of this part of ISO 22442, see Annex A.
  language:
  - en
  script:
  - Latn
  format: text/plain
- content: |-
    L'ISO 22442-1:2015 s'applique aux dispositifs médicaux autres que les dispositifs médicaux de diagnostic in vitro, dans la fabrication desquels entrent des matériaux d'origine animale non viables ou rendus non viables. Associée à l'ISO 14971, elle spécifie un mode opératoire permettant d'identifier les dangers et les situations dangereuses associés à de tels dispositifs, d'estimer et d'évaluer les risques qui en découlent, de maîtriser ces risques et de surveiller l'efficacité de cette maîtrise. En outre, elle décrit le processus décisionnel relatif à l'acceptabilité du risque résiduel, en tenant compte du rapport entre le risque résiduel, tel que défini dans l'ISO 14971, et le bénéfice médical escompté par rapport aux solutions de remplacement disponibles. L'ISO 22442-1:2015 est destinée à fournir des exigences et des lignes directrices pour la gestion des risques associée aux dangers typiques des dispositifs médicaux dans la fabrication desquels entrent des tissus ou des dérivés d'origine animale, notamment:
    a)    la contamination par des bactéries, des moisissures ou des levures;
    b)    la contamination par des virus;
    c)    la contamination par des agents responsables d'encéphalopathies spongiformes transmissibles (EST);
    d)    un matériau provoquant des réactions pyrogènes, immunologiques ou toxicologiques indésirables.
  language:
  - fr
  script:
  - Latn
  format: text/plain
docstatus:
  stage:
    value: '95'
  substage:
    value: '99'
copyright:
- owner:
  - name:
    - content: ISO
  from: '2015'
relation:
- type: obsoletes
  bibitem:
    id: ISO22442-1-2007
    type: standard
    docid:
    - id: ISO 22442-1:2007
      type: ISO
      primary: true
    formattedref:
      content: ISO 22442-1:2007
      format: text/plain
- type: updates
  bibitem:
    id: ISO22442-1-2020
    type: standard
    docid:
    - id: ISO 22442-1:2020
      type: ISO
      primary: true
    date:
    - type: circulated
      value: '2020-09-15'
    formattedref:
      content: ISO 22442-1:2020
      format: text/plain
place:
- Geneva
ext:
  schema-version: v1.0.3
  doctype:
    type: international-standard
  editorialgroup:
    technical_committee:
    - name: Biological and clinical evaluation of medical devices
      number: 194
      type: TC
      identifier: ISO/TC 194
  ics:
  - code: 11.100.20
    text: Biological evaluation of medical devices
  structuredidentifier:
    project_number: '68553'
    type: ISO
